ATE166652T1 - Isolierung und struktur von spongistatin 1 und dessen verwendung als antitumor-mittel - Google Patents

Isolierung und struktur von spongistatin 1 und dessen verwendung als antitumor-mittel

Info

Publication number
ATE166652T1
ATE166652T1 AT94300362T AT94300362T ATE166652T1 AT E166652 T1 ATE166652 T1 AT E166652T1 AT 94300362 T AT94300362 T AT 94300362T AT 94300362 T AT94300362 T AT 94300362T AT E166652 T1 ATE166652 T1 AT E166652T1
Authority
AT
Austria
Prior art keywords
spongistatin
found
isolation
antitumor agent
tci50
Prior art date
Application number
AT94300362T
Other languages
English (en)
Inventor
George R Pettit
Cherry L Herald
Zbigniew A Cichacz
Original Assignee
Univ Arizona
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona filed Critical Univ Arizona
Application granted granted Critical
Publication of ATE166652T1 publication Critical patent/ATE166652T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/445—The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT94300362T 1993-01-19 1994-01-19 Isolierung und struktur von spongistatin 1 und dessen verwendung als antitumor-mittel ATE166652T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/006,270 US5436400A (en) 1993-01-19 1993-01-19 Isolation and structure of spongistatin 1

Publications (1)

Publication Number Publication Date
ATE166652T1 true ATE166652T1 (de) 1998-06-15

Family

ID=21720096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94300362T ATE166652T1 (de) 1993-01-19 1994-01-19 Isolierung und struktur von spongistatin 1 und dessen verwendung als antitumor-mittel

Country Status (8)

Country Link
US (1) US5436400A (de)
EP (1) EP0608111B1 (de)
JP (1) JPH072866A (de)
AT (1) ATE166652T1 (de)
CA (1) CA2113656C (de)
DE (1) DE69410492T2 (de)
DK (1) DK0608111T3 (de)
ES (1) ES2119077T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393897A (en) * 1993-07-02 1995-02-28 Arizona Board Of Regents Acting On Behalf Of Arizona State University Isolation and structure of spongistatins 5,7,8 and 9
WO1997048278A1 (en) * 1996-06-18 1997-12-24 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of The Arizona State University Antifungal activity of the spongistatins
US5883120A (en) * 1997-06-16 1999-03-16 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Antifungal activity of the spongistatins
US5952376A (en) * 1997-11-07 1999-09-14 The Trustees Of The University Of Pennsylvania Trienyl compounds
US6521661B1 (en) 2000-07-20 2003-02-18 Harbor Branch Oceanographic Institution, Inc. Cyclic peroxides as novel antifungal agents
US20180030095A1 (en) 2015-02-13 2018-02-01 George Robert Pettit Silstatin compounds
WO2019094709A1 (en) 2017-11-09 2019-05-16 Pettit George R Betulastatin compounds
CN114605430B (zh) * 2022-03-18 2023-09-05 中国科学院海洋研究所 一种大环双内酯类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833257A (en) * 1986-07-28 1989-05-23 Arizona Board Of Regents Compositions of matter and methods of using same
US5196447A (en) * 1991-08-08 1993-03-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University Neristatin 1

Also Published As

Publication number Publication date
ES2119077T3 (es) 1998-10-01
CA2113656C (en) 2000-07-18
EP0608111A1 (de) 1994-07-27
DK0608111T3 (da) 1999-01-18
US5436400A (en) 1995-07-25
CA2113656A1 (en) 1994-07-20
DE69410492T2 (de) 1998-11-05
JPH072866A (ja) 1995-01-06
EP0608111B1 (de) 1998-05-27
DE69410492D1 (de) 1998-07-02

Similar Documents

Publication Publication Date Title
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
DK0751959T3 (da) Modificerede polypeptider med forøget biologisk aktivitet
ES2085636T3 (es) Traje de baño.
MX9200675A (es) Derivados de 2,4-diaminoquinazolinas para mejorar la actividad antitumoral.
AU550007B2 (en) Complex of 4-hydroxy-2-methyl-n-2-pyridyl-2h-1, 2-benzothiazine-3-carboxamide-1, 1-dioxide and alpha, beta, gamma-type cyclodextrin
GB8606821D0 (en) Corneal reprofiling
WO1994011010A3 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
BR9300691A (pt) Composicao de xampu para cabelo bem como seu uso
AU6256996A (en) Use of vitamin D4 derivatives for treating skin disorders
ES2022443B3 (es) Utilizacion fungicida de un derivado de cianopirrol.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ATE166652T1 (de) Isolierung und struktur von spongistatin 1 und dessen verwendung als antitumor-mittel
IT1263004B (it) Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
DE69314942D1 (de) N-acylglutamin-derivate
DK0565519T3 (da) Illudinanaloge som antitumormidler
EP0345248A3 (de) Verwendung des Enzym-Cofaktors NADPH zur Herstellung eines Arzneimittels sowie daraus hergestelltes Arzneimittel und Verfahren zu seiner Herstellung
ES2154290T3 (es) Estimulacion de la diferenciacion celular por sindecano.
EP0971725A4 (de) Verfahren zur behandlung von narbengewebe
AU553838B2 (en) Chroman derivatives
IT1227030B (it) Pannello ecologico per l'ottenimento, mediante incernieramento con uguali pannelli, in particolare di difese spondali
IT8421358A0 (it) Derivato della ranitidina utile nel trattamento dell'ulcera.
IT225678Y1 (it) Supporto atto a permettere l'applicazione rapida di ante con cerniera ai corpi dei mobili.
BR6900938U (pt) Mesa giratoria de usinagem e recuperacao de lingoteiras,com movimento de translacao
TW238246B (en) Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor
IT207022Z2 (it) Attrezzo atto a fungere da schienale in spiagge o su terreni simili.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee